NCT03388268View on ClinicalTrials.gov

TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 29, 2017

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Clostridium Difficile InfectionDiarrhea
Interventions
DRUG

Oral Vancomycin

Oral vancomycin 125mg 4 times per day

DRUG

Placebo

Sugar liquid manufactured to mimic oral vancomycin 125mg

DEVICE

Toxin enzyme immunoassay

EIA assay: Wampole/Tech Lab Tox A/B II

DEVICE

Nuceleic acid amplification test

NAAT: Xpert C. difficile, Cepheid

Trial Locations (1)

63110

Washington University, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03388268 - TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment | Biotech Hunter | Biotech Hunter